Policy challenges in ultra-rare cancers: Ethical, Social, anbd Legal implications of Melanoma Pevention and Diagnosis in Children, Adolescents, and Young Adults

dc.contributor.authorRefolo, Pietro
dc.contributor.authorRaimondi, Constanza
dc.contributor.authorBattaglia, Livio
dc.contributor.authorBorràs, Josep Maria
dc.contributor.authorClosa, Paula
dc.contributor.authorScalzo, Alessandra lo
dc.contributor.authorMarchetti, Marco
dc.contributor.authorMuñoz López, Sonia
dc.contributor.authorPrades Pérez, Joan
dc.contributor.authorSampietro Colom, Laura
dc.contributor.authorSacchini, Dario
dc.date.accessioned2026-03-18T14:56:08Z
dc.date.available2026-03-18T14:56:08Z
dc.date.issued2025
dc.date.updated2026-03-18T14:56:08Z
dc.description.abstractAbstract: Background: The ultra-rare nature of melanoma in children, adolescents, and young adults poses significant challenges to the development and implementation of effective prevention and diagnostic strategies. This article delves into the ELSIs surrounding these strategies, placing particular emphasis on the transformative potential of AI-driven tools and applications. Methods: Using an exploratory sequential mixed methods approach, this study integrated a PICO-guided literature review and qualitative insights from two focus groups. The review included 26 peer-reviewed articles published in English from January 2019 to January 2024, addressing ELSIs in melanoma, rare diseases, and AI in dermatology. Focus groups included a March 2024 session in Berlin with 15 stakeholders (patients, caregivers, advocates, healthcare professionals) and a November 2024 online session with 5 interdisciplinary experts. Results: Six key priorities for healthcare policies emerged: addressing cultural factors, such as the glorification of tanned skin; enhancing professional training for accurate diagnosis; balancing the risks of overdiagnosis and underdiagnosis; promoting patient autonomy through transparent communication; reducing inequalities to ensure equitable access to care; and making ethical and legal use of AI in healthcare. Conclusion: These priorities provide a comprehensive framework for advancing the prevention and diagnosis of melanoma in children, adolescents, and young adults, leveraging AI technologies while prioritizing equitable and patient-centered healthcare delivery.
dc.format.extent321 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec754547
dc.identifier.issn2227-9032
dc.identifier.pmid39942510
dc.identifier.urihttps://hdl.handle.net/2445/228283
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/healthcare13030321
dc.relation.ispartofHealthcare, 2025, vol. 321
dc.relation.urihttps://doi.org/10.3390/healthcare13030321
dc.rightscc-by (c) Refolo, P. et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer en els infants
dc.subject.classificationMelanoma
dc.subject.otherCancer in children
dc.subject.otherMelanoma
dc.titlePolicy challenges in ultra-rare cancers: Ethical, Social, anbd Legal implications of Melanoma Pevention and Diagnosis in Children, Adolescents, and Young Adults
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
879385.pdf
Mida:
236.26 KB
Format:
Adobe Portable Document Format